drugset / Trial / NCT06211023
A Study of SHR-A1921 With or Without Carboplatin in Subjects With Ovarian Cancer
RandomizedParallel-groupOpen-labelTreatment
Summary
This is an open-label, randomized, controlled, two-part study to evaluate the safety and efficacy of SHR-A1921 with or without carboplatin verus investigator's choice of platinum-based doublet chemotherapy in subjects with recurrent epithelial ovarian cancer.
Timeline
- Start
- 2024-02-15
- Primary completion
- 2026-06-15
- Completion
- 2026-06-15
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Carboplatin | Small molecule | 4 unknown | — |
| Subject | Carboplatin | Small molecule | 5 unknown | — |
| Subject | SHR-1921 | Unknown | — | — |